- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05425108
Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device
June 30, 2022 updated by: Kubota Vision Inc.
Effectiveness of Binocular Peripheral Myopic Projected Defocus on Ocular Biometrics Using a Clinical Prototype Device
Kubota Vision Inc. has developed a spectacle-like prototype device which is designed to be used as a light-based therapy to reduce myopia progression.
In this study, we aim to observe the ocular biometric and refractive changes following binocular part-time wear of the clinical prototype device over a course of 12 months and compare that to 12 months of no clinical prototype device use (control).
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Clinical Trials Helpdesk
- Phone Number: (206) 805-8310
- Email: ClinicalTrails@kubotavision.com
Study Locations
-
-
New York
-
New York, New York, United States, 10022
- Recruiting
- Manhattan Vision Associates/institute of Vision Research
-
Contact:
- Study Coordinator
- Phone Number: 212-688-4277
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Spherical equivalent -0.50 to -5.50 diopters
- visual acuity of at least 20/25 in each eye
Exclusion Criteria:
- history of ocular trauma or major eye surgery
- active ocular infection
- any prior history or participation in myopia control treatments within the past 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
|
|
Active Comparator: CP1 device
|
Binocular active projection of defocused image in the peripheral visual field
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Central axial length
Time Frame: 12 months
|
12 months
|
Cycloplegic refraction
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arkady Selenow, OD, Manhattan Vision Associates/institute of Vision Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 23, 2022
Primary Completion (Anticipated)
August 1, 2023
Study Completion (Anticipated)
August 1, 2023
Study Registration Dates
First Submitted
June 15, 2022
First Submitted That Met QC Criteria
June 15, 2022
First Posted (Actual)
June 21, 2022
Study Record Updates
Last Update Posted (Actual)
July 6, 2022
Last Update Submitted That Met QC Criteria
June 30, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP1 Pilot
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on Binocular CP1
-
Massachusetts Eye and Ear InfirmaryCompletedStrabismus | AmblyopiaUnited States
-
University College, LondonNational Institute for Health Research, United KingdomCompletedEye Diseases | Eye Infections | Eye InflammationUnited Kingdom
-
Moorfields Eye Hospital NHS Foundation TrustCompleted
-
University College, LondonCompletedGlaucoma | Strabismus | Healthy Volunteers | Retinal DiseaseUnited Kingdom
-
University of WaterlooMcGill University; Retina Foundation of the Southwest; Queensland University...CompletedAmblyopia | Binocular Vision DisorderUnited States, Australia
-
Retina Foundation of the SouthwestActive, not recruiting
-
Shahid Beheshti University of Medical SciencesUnknownThe New Treatment in Amblyopia TherapyIran, Islamic Republic of
-
University College, LondonCompletedHealthy Volunteers | Pupil Anomaly | Relative Afferent Pupil DefectUnited Kingdom
-
Shahid Beheshti University of Medical SciencesUnknownAmblyopiaIran, Islamic Republic of